|
|
|
|
| Discover the latest advancements in cell therapy supply chains! Join Cell & Gene Live as we explore cutting-edge automation, storage solutions, and cryopreservation techniques for iPSCs. Learn strategies to maintain cell viability, functionality, and therapeutic potential while enhancing long-term stability and clinical applicability. Don’t miss this opportunity to gain valuable insights from industry experts. Registration is free! |
|
|
|
|
By Alex Klarer, Founder, Managing Director, Engelex | This article explores how the disparity between the number of CDMOs and CGT clinical trials came about and how the market for manufacturing services will change as a result. | |
|
|
| The Role Of Platform Processes In Cell Therapy | Webinar | BioCentriq | Learn how the streamlined processes and reduced complexity enabled by a platform approach can lead to scalable manufacturing, rapid delivery, and expanded patient access for cell therapies. |
|
|
|
| The Challenges And Opportunities Of Real-World Evidence | Article | Kaitlyn Rouillard Vargas, Ph.D., Kymanox Corporation | The FDA's Real-World Evidence framework addresses challenges in using Real-World Data for regulatory decisions, emphasizing data reliability, bias management, and successful case studies. |
|
|
| A Continuous Electroporation System For Viral Gene Therapy | Article | By Takashi Yakushiji and Yoichi Nagai, FUJIFILM Diosynth Biotechnologies | Explore the development work involved for the individual technologies that make up an innovative and scalable, chemical-free continuous viral vector production platform. |
|
|
| Smoothing The Path To Successful mRNA Manufacturing | e-book | Novartis Contract Manufacturing | Producing mRNA therapeutics requires navigating complex manufacturing challenges. A strategic partnership with an integrated CMO streamlines manufacturing processes and reduces costs. |
|
|
|
| A New Centre For Continuous mRNA Manufacturing | Article | ReciBioPharm | A partnership between academia, regulatory agencies, and manufacturing organizations has the potential to reshape the way we produce and distribute mRNA-based therapies. |
|
|
| Solving The AAV Scalability Challenge | White Paper | By Ahmed Youssef and Melanie Plath, Ascend & ABL Inc. | Explore the effectiveness of a flexible, scalable AAV manufacturing platform that incorporates well-characterized bioreactors and advanced production systems to develop cost-effective gene therapies. |
|
|
|
|
|
|
|
|
| Connect With Cell & Gene: |
|
|
|
